-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - Concentrations of Hb in nondialysis-dependent CKD patients who have anemia can be improved
with oral … patients (who may or may not be receiving ESA treatment), intravenous iron therapy is preferred
over oral … care, and
others with experience in making health care decisions. … August 29, 2011
17
35 exp Predictive Value of Tests/ 107,715
36 exp ROC CURVE/ 18,819
37 exp Mass … Screening/ 84,398
38 exp diagnosis/ 5,287,805
39 exp REPRODUCIBILITY OF RESULTS/ 208,459
40 exp
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
March 01, 2012 - factor Xa inhibitors, injectable or oral direct thrombin
inhibitors [DTIs], oral vitamin K antagonists … Classes include oral antiplatelet agents,
injectable LMWHs, injectable UFH, injectable or oral
factor … Xa inhibitors, injectable or oral DTIs, oral VKAs,
and mechanical interventions. … Additionally, most trials
evaluated intermediate health outcomes and did not
address final health outcomes … In a controlled
observational study, oral VKAs had significantly fewer
fatal PE events versus oral
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
January 01, 2019 - part, as the basis for the development of clinical practice
guidelines and other quality enhancement tools … relief in sore throat: systematic review and
meta-analysis
2009 BMJ
16458764 Self-monitoring of oral … - the case of screening for abdominal
aortic aneurysm in Sweden
2006 Health Econ
16706572 Comprehensive … Care
16707071 The cost-effectiveness of screening for oral cancer in
primary care
2006 Health Technol … economic model for breast cancer screening
2008 Value Health
18272361 Surveillance of Barrett's
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … Patients had sUA
levels of 6.5 mg/dL or higher at screening, were on stable allopurinol doses (≥300 … more, and at least one measurable tophus received lesinurad 200 mg or 400
mg in combination with oral … Health care delivery infrastructure and patient management: As an oral medication,
lesinurad is not
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - The symptoms of PAH can be
Effective Health Care Program
The Effective Health Care Program
was initiated … The object is to help
consumers, health care providers,
and others in making informed
choices among … Symptoms that are
present at rest suggest advanced disease.1
Effective
Health Care
Effective Health … Standard therapies included
supportive therapy (diuretics, oxygen, digoxin, oral
anticoagulants) with … Our findings do not support any recommendations
for replacing existing measurement tools to assess
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … Ivacaftor tablets are
indicated for oral administration, one 150 mg dose every 12 hours for patients … drug would
affect current care processes and patient management by offering patients a convenient oral … Zithromax (azithromycin tablets) and (azithromycin
for oral suspension) prescribing information.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … condition, pharmacotherapy (e.g.,
ES-3
buprenorphine, naltrexone) is already available in oral … The toolkit contains pain management guidelines, opioid risk-assessment tools,
precautions for opioid … identified by the physician as a naloxone priority patient (according to the opioid risk-
assessment tools
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
August 08, 2019 - patient education; (3) clinician and patient values and preferences related to opioids; (4)
urine drug screening … patient
education; (3) clinician and patient values and preferences related to opioids; (4)
urine drug screening … prescription drug monitoring program data; (6)
availability of close followup
Nonopioid therapy: Oral … Non-prescription (OTC) oral analgesics for acute pain - an overview
of Cochrane reviews. … US Department of Health and Human Services Office of the Assistant Secretary for Health.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … EASD 2011: the next-
generation of diabetes management tools.
[internet]. … http://www.clinica.co.uk/marketsector/ivds/EAS
D-2011-The-next-generation-of-diabetes-
management-tools … Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … Antithrombotic agents include
vitamin K antagonists, aspirin, low-molecular-weight heparin, and oral … Unmet need and health outcomes: For the small population of patients with HoFH, no
effective oral pharmacologic … Juxtapid (lomitapide) capsules, for oral use
prescribing information.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
May 08, 2013 - reported
aspiration risk (and as noted by the reviewer such patients
would have been excluded from oral … tools,
distinguishes between screening for disease detection such as
breast cancer and screening for … health education model and discusses
efficacy and effectiveness of a screening program combined
with … health education. … A comparison of screening for disease detection
and screening for risk factors.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - One health systems expert stated, “Adherence issues with
oral drugs and insulin are significant.”21 … thought the MiniMed 530G has good potential to fill the unmet need for improved
diabetes management tools … care delivery infrastructure, although
candidates would require preliminary respiratory screening … Choice of who are the best candidates for the steroid implant
may require some level of screening for … Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - or “digital medicine,” has been
developed for use with oral pill or capsule medications prescribed … Protocol interventions include screening for cognitive impairment, delirium,
risk of adverse health … information with
caregivers and providers, and to incorporate individualized behavior support tools … estimated 150 in development.64
Current Approach to Care
Traditional EDs may incorporate cognitive screenings … (usually administered on an as-needed
basis to ED patients) and other geriatric clinical tools or
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
May 01, 2020 - our database, and
additional relevant articles not already under
consideration were retrieved for screening … Articles included by either reviewer underwent
full-text screening. … Of these, 915 were
excluded at the full-text screening stage, leaving
167 articles for data abstraction … • Studies of these tools/methods should also
explore the complexity of decision making that
needs … Tools for optimizing the outcomes of
labor safely.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Mifepristone (Korlym™,
Corcept Therapeutics, Inc., Menlo Park, CA) is an oral glucocorticoid-II receptor … They said the following factors would contribute to diffusion of mifepristone, if approved:
its oral … implant rather than medical and talk therapy), but because it has the potential to shift care from oral
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Mifepristone (Korlym
™
[formerly Corlux], Corcept
Therapeutics, Inc., Menlo Park, CA) is an oral … Mifepristone (Korlym
™
[formerly Corlux], Corcept Therapeutics, Inc., Menlo Park, CA) is an
oral … Of soldiers referred via the Post Deployment Health Assessment
screening process, only 54% follow through
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … comparing oral to nasal inhalation. … Placebo-
controlled phase 3 study of oral BG-12 for
relapsing multiple sclerosis. … Dihydroergotamine
(migraine, Tempo-inhaled/oral), MAP. [10 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … Treatment for severe
ES-5
SBS may involve oral rehydration solutions, intravenous nutrition … Treatment for severe SBS may involve oral rehydration solutions,
intravenous nutrition delivery, and … PG course: per oral
endoscopic myotomy (POEM) course outline and
table of contents.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - Reviewers will attend
a screening training session, and screening forms will be pilot tested. … A broad screen of titles and
abstracts will be followed by full-text screening of articles deemed relevant … Include only:
° Niacin (≤ 250 mg/d)
° Vitamins: A, D, E, K
° Vitamin D + calcium
° Magnesium (oral … Available at:
http://www.igh.org/Cochrane/tools/Ch10_Reporting.pdf
3. … www.effectivehealthcare.ahrq.gov/ehc/products/60/318/Methods-Guide_Prepublication-Draft_03-2011.pdf�
http://www.igh.org/Cochrane/tools
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … systems, health business, health
administration, health policy). … Tofacitinib is indicated for oral
administration, 5 mg twice daily. … Xeljanz (tofacitinib) tablets for oral
administration prescribing information.